Relapsed Lymphoma

Explore clinical trials studying Relapsed Lymphoma. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed Lymphoma trial results

Recruiting

NCT06563596

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

The Ohio State University Wexner Medical Center Columbus, Ohio, United States

Completed

NCT01742988

Conditions: Double-expressor Lymphoma (DEL), Double-hit Lymphoma (DHL), Hemic and Lymphatic Diseases, +18 more
Locations: USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

Florida Cancer Specialists Sarasota, Florida, United States

Winship Cancer Institute, Emory University Atlanta, Georgia, United States

University of Chicago Medicine Chicago, Illinois, United States

Completed

NCT01929720

Conditions: Adnexal Diseases, Anxiety Disorder, Anxiety Disorders, +85 more
Locations: Wexner Medical Center at The Ohio State University Department of Psychiatry Columbus, Ohio, United States

Completed

NCT00054808

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Genta Berkeley Heights, New Jersey, United States